Amyloid precursor protein as a fibrosis marker in infants with biliary atresia.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
received:
09
02
2024
accepted:
21
08
2024
revised:
29
07
2024
medline:
29
9
2024
pubmed:
29
9
2024
entrez:
28
9
2024
Statut:
aheadofprint
Résumé
Biliary atresia (BA) is a rare condition of unknown origin in newborns with jaundice. In BA bile ducts are non-functional, causing neonatal cholestasis and following liver fibrosis and failure. This retrospective study included liver biopsies of 14 infants with BA aged [mean ± SD] 63 ± 23 days. Patients were grouped according to the clinical course (jaundice-free vs recurrent jaundice vs required liver transplantation or liver fibrosis (Ishak fibrosis score)) and followed for 1.61-5.64 years (mean 4.03). Transcriptome profiles were assessed using a panel of 768 fibrosis-specific genes, reanalyzed via qRT-PCR, and confirmed via immunostaining. Plasma from an additional 30 BA infants and 10 age-matched controls were used for amyloid precursor protein (APP) quantification by ELISA. Different clinical outcome groups showed a homogeneous mRNA expression. Altered amyloid-metabolism-related gene expression was found between cases with Ishak fibrosis score greater than 4. Immunostaining confirmed a distinct presence of APP in the livers of all BA subjects. APP plasma levels were higher in BA than in age-matched controls and correlated with the histological fibrosis grade. These results suggest that amyloidosis may contribute to BA and liver fibrosis, indicating that APP could serve as a potential liquid biomarker for these conditions. Biliary atresia patients with higher fibrosis scores according to Ishak have higher hepatic expression of amyloid-related genes while amyloid precursor protein accumulates in the liver and increases in the circulation. After a recent study revealed beta-amyloid deposition as a mechanism potentially involved in biliary atresia, we were able to correlate amyloid-metabolism-related transcript levels as well as amyloid precursor protein tissue and plasma levels with the degree of hepatic fibrosis. These findings suggest that amyloid precursor protein is a fibrosis marker in infants with biliary atresia, reinforcing the role of amyloid metabolism in the pathogenesis of this serious disease.
Sections du résumé
BACKGROUND
BACKGROUND
Biliary atresia (BA) is a rare condition of unknown origin in newborns with jaundice. In BA bile ducts are non-functional, causing neonatal cholestasis and following liver fibrosis and failure.
METHODS
METHODS
This retrospective study included liver biopsies of 14 infants with BA aged [mean ± SD] 63 ± 23 days. Patients were grouped according to the clinical course (jaundice-free vs recurrent jaundice vs required liver transplantation or liver fibrosis (Ishak fibrosis score)) and followed for 1.61-5.64 years (mean 4.03). Transcriptome profiles were assessed using a panel of 768 fibrosis-specific genes, reanalyzed via qRT-PCR, and confirmed via immunostaining. Plasma from an additional 30 BA infants and 10 age-matched controls were used for amyloid precursor protein (APP) quantification by ELISA.
RESULTS
RESULTS
Different clinical outcome groups showed a homogeneous mRNA expression. Altered amyloid-metabolism-related gene expression was found between cases with Ishak fibrosis score greater than 4. Immunostaining confirmed a distinct presence of APP in the livers of all BA subjects. APP plasma levels were higher in BA than in age-matched controls and correlated with the histological fibrosis grade.
CONCLUSIONS
CONCLUSIONS
These results suggest that amyloidosis may contribute to BA and liver fibrosis, indicating that APP could serve as a potential liquid biomarker for these conditions.
IMPACT
CONCLUSIONS
Biliary atresia patients with higher fibrosis scores according to Ishak have higher hepatic expression of amyloid-related genes while amyloid precursor protein accumulates in the liver and increases in the circulation. After a recent study revealed beta-amyloid deposition as a mechanism potentially involved in biliary atresia, we were able to correlate amyloid-metabolism-related transcript levels as well as amyloid precursor protein tissue and plasma levels with the degree of hepatic fibrosis. These findings suggest that amyloid precursor protein is a fibrosis marker in infants with biliary atresia, reinforcing the role of amyloid metabolism in the pathogenesis of this serious disease.
Identifiants
pubmed: 39341941
doi: 10.1038/s41390-024-03582-w
pii: 10.1038/s41390-024-03582-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Jiang, J. et al. Epidemiological characteristics and risk factors of biliary atresia: a case-control study. BMJ Open. 11, e049354 (2021).
pubmed: 34903536
pmcid: 8671910
doi: 10.1136/bmjopen-2021-049354
Livesey, E. et al. Epidemiology of biliary atresia in England and Wales (1999–2006). Arch. Dis. Child Fetal Neonatal Ed. 94, F451–F455 (2009).
pubmed: 19457876
doi: 10.1136/adc.2009.159780
The, N. S. et al. National Birth Defects Prevention Study. Risk factors for isolated biliary atresia, National Birth Defects Prevention Study, 1997–2002. Am. J. Med. Genet. A. 143A, 2274–2284 (2007).
pubmed: 17726689
doi: 10.1002/ajmg.a.31926
Medappil, N. et al. Kasai portoenterostomy for biliary atresia - surgical precautions for better outcomes. J. Pediatr. Surg. 54, 868–869 (2019).
pubmed: 30580834
doi: 10.1016/j.jpedsurg.2018.09.028
Davenport, M. et al. Surgical and medical aspects of the initial treatment of biliary atresia: position paper. J. Clin. Med. 11, 6601 (2022).
pubmed: 36362829
pmcid: 9656543
doi: 10.3390/jcm11216601
Madadi-Sanjani, O. et al. Long-term outcome and necessity of liver transplantation in infants with biliary atresia are independent of cytokine milieu in native liver and serum. Cytokine 111, 382–388 (2018).
pubmed: 30300856
doi: 10.1016/j.cyto.2018.09.010
Leyva-Vega, M. et al. Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3. Am. J. Med. Genet A. 152A, 886–895 (2010).
pubmed: 20358598
pmcid: 2914625
doi: 10.1002/ajmg.a.33332
Ningappa, M. et al. The role of ARF6 in biliary atresia. PLoS ONE 10, e0138381 (2015).
pubmed: 26379158
pmcid: 4574480
doi: 10.1371/journal.pone.0138381
Chen, Y. et al. A genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1. PLoS Genet. 14, e1007532 (2018).
pubmed: 30102696
pmcid: 6107291
doi: 10.1371/journal.pgen.1007532
Garcia-Barceló, M. M. et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum. Mol. Genet. 19, 2917–2925 (2010).
pubmed: 20460270
pmcid: 2893814
doi: 10.1093/hmg/ddq196
Rajagopalan, R. et al. Exome sequencing in individuals with isolated biliary atresia. Sci. Rep. 10, 2709 (2020).
pubmed: 32066793
pmcid: 7026070
doi: 10.1038/s41598-020-59379-4
Glessner, J. T. et al. Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes. J. Hepatol. 79, 1385–1395 (2023).
pubmed: 37572794
pmcid: 10729795
doi: 10.1016/j.jhep.2023.07.039
Luo, Z., Shivakumar, P., Mourya, R., Gutta, S. & Bezerra, J. A. Gene expression signatures associated with survival times of pediatric patients with biliary atresia identify potential therapeutic agents. Gastroenterology 157, 1138–1152.e14 (2019).
pubmed: 31228442
doi: 10.1053/j.gastro.2019.06.017
Everhart, J. E. et al. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51, 585–594 (2010).
pubmed: 20101752
doi: 10.1002/hep.23315
Kamp, J. C. et al. Fibrosis-related gene profiling in liver biopsies of PiZZ α1-antitrypsin children with different clinical courses. Int J. Mol. Sci. 24, 2485 (2023).
pubmed: 36768808
pmcid: 9916468
doi: 10.3390/ijms24032485
Puchtler, H., Sweat, F. & Levine, M. On the binding of congo red by amyloid. J. Histochem. Cytochem. 10, 355–364 (1962).
doi: 10.1177/10.3.355
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772
doi: 10.1038/nmeth.2019
Liu, X., Liu, Y. & Ji, S. Secretases related to amyloid precursor protein processing. Membranes 11, 983 (2021).
pubmed: 34940484
pmcid: 8706128
doi: 10.3390/membranes11120983
Ozdogan, E. & Arikan, C. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy. Clin. Exp. Pediatr. 66, 110–124 (2023).
pubmed: 36550776
doi: 10.3345/cep.2022.00367
Schoen, B. T., Lee, H., Sullivan, K. & Ricketts, R. R. The Kasai portoenterostomy: when is it too late? J. Pediatr. Surg. 36, 97–99 (2001).
pubmed: 11150445
doi: 10.1053/jpsu.2001.20020
Davenport, M., Gonde, C., Narayanaswamy, B., Mieli-Vergani, G. & Tredger, J. M. Soluble adhesion molecule profiling in preoperative infants with biliary atresia. J. Pediatr. Surg. 40, 1464–1469 (2005).
pubmed: 16150350
doi: 10.1016/j.jpedsurg.2005.05.050
Langenburg, S. E., Poulik, J., Goretsky, M., Klein, A. A. & Klein, M. D. Bile duct size does not predict success of portoenterostomy for biliary atresia. J. Pediatr. Surg. 35, 1006–1007 (2000).
pubmed: 10873055
doi: 10.1053/jpsu.2000.6954
Weerasooriya, V. S., White, F. V. & Shepherd, R. W. Hepatic fibrosis and survival in biliary atresia. J. Pediatr. 144, 123–125 (2004).
pubmed: 14722530
doi: 10.1016/j.jpeds.2003.09.042
Wu, L. N., Zhu, Z. J. & Sun, L. Y. Genetic factors and their role in the pathogenesis of biliary atresia. Front. Pediatr. 10, 912154 (2022).
pubmed: 35844731
pmcid: 9277099
doi: 10.3389/fped.2022.912154
Stone, R. C. et al. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res. 365, 495–506 (2016).
pubmed: 27461257
pmcid: 5011038
doi: 10.1007/s00441-016-2464-0
Venkat, V. et al. Childhood Liver Disease Research Network. Modeling outcomes in children with biliary atresia with native liver after 2 years of age. Hepatol. Commun. 4, 1824–1834 (2020).
pubmed: 33305153
pmcid: 7706301
doi: 10.1002/hep4.1602
Gunadi et al. Collagen gene cluster expression and liver fibrogenesis in patients with biliary atresia: a preliminary study. BMC Res. Notes 16, 356 (2023).
pubmed: 38041174
pmcid: 10690962
doi: 10.1186/s13104-023-06636-0
Kerola, A. et al. Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy. Surgery 162, 548–556 (2017).
pubmed: 28655415
doi: 10.1016/j.surg.2017.04.013
Jonigk, D. et al. Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation. J. Pathol. Clin. Res. 3, 17–28 (2016).
pubmed: 28138398
pmcid: 5259562
doi: 10.1002/cjp2.60
Madadi-Sanjani, O. et al. Growth factors assessed during Kasai procedure in liver and serum are not predictive for the postoperative liver deterioration in infants with biliary atresia. J. Clin. Med. 10, 1978 (2021).
pubmed: 34062967
pmcid: 8124311
doi: 10.3390/jcm10091978
Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B. & Christensen, S. T. Cellular signalling by primary cilia in development, organ function and disease. Nat. Rev. Nephrol. 15, 199–219 (2019).
pubmed: 30733609
pmcid: 6426138
doi: 10.1038/s41581-019-0116-9
Tam, P. K. H., Yiu, R. S., Lendahl, U. & Andersson, E. R. Cholangiopathies - towards a molecular understanding. EBioMedicine 35, 381–393 (2018).
pubmed: 30236451
pmcid: 6161480
doi: 10.1016/j.ebiom.2018.08.024
McGaughran, J. M., Donnai, D. & Clayton-Smith, J. Biliary atresia in Kabuki syndrome. Am. J. Med Genet. 91, 157–158 (2000).
pubmed: 10748418
doi: 10.1002/(SICI)1096-8628(20000313)91:2<157::AID-AJMG16>3.0.CO;2-F
Lam, W. Y. et al. Identification of a wide spectrum of ciliary gene mutations in nonsyndromic biliary atresia patients implicates ciliary dysfunction as a novel disease mechanism. EBioMedicine 71, 103530 (2021).
pubmed: 34455394
pmcid: 8403738
doi: 10.1016/j.ebiom.2021.103530
Davey, M. G., McTeir, L., Barrie, A. M., Freem, L. J. & Stephen, L. A. Loss of cilia causes embryonic lung hypoplasia, liver fibrosis, and cholestasis in the talpid3 ciliopathy mutant. Organogenesis 10, 177–185 (2014).
pubmed: 24743779
pmcid: 4154951
doi: 10.4161/org.28819
Shen, W., Chen, G., Dong, R., Zhao, R. & Zheng, S. MicroRNA-21/PTEN/Akt axis in the fibrogenesis of biliary atresia. J. Pediatr. Surg. 49, 1738–1741 (2014).
pubmed: 25487473
doi: 10.1016/j.jpedsurg.2014.09.009
Babu, R. O. et al. Beta-amyloid deposition around hepatic bile ducts is a novel pathobiological and diagnostic feature of biliary atresia. J. Hepatol. 73, 1391–1403 (2020).
pubmed: 32553668
doi: 10.1016/j.jhep.2020.06.012
Tian, X. et al. amyloid deposition in biliary atresia reduces liver regeneration by inhibiting energy metabolism and mammalian target of rapamycin signaling. Clin. Transl. Gastroenterol. 13, e00536 (2022).
pubmed: 36137184
pmcid: 10476755
doi: 10.14309/ctg.0000000000000536
Nagi, S. A. et al. Does amyloid b precursor protein gene expression have a role in diagnosis of biliary atresia? Clin. Exp. Hepatol. 9, 335–345 (2023).
pubmed: 38774198
pmcid: 11103800
doi: 10.5114/ceh.2023.132818
Chou, C. W., Huang, Y. K., Kuo, T. T., Liu, J. P. & Sher, Y. P. An overview of ADAM9: structure, activation, and regulation in human diseases. Int J. Mol. Sci. 21, 7790 (2020).
pubmed: 33096780
pmcid: 7590139
doi: 10.3390/ijms21207790
Bormann, T. et al. Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice. Respir. Res. 23, 180 (2022).
pubmed: 35804363
pmcid: 9270768
doi: 10.1186/s12931-022-02105-7
Giebeler, N. & Zigrino, P. A disintegrin and metalloprotease (ADAM): historical overview of their functions. Toxins 8, 122 (2016).
pubmed: 27120619
pmcid: 4848645
doi: 10.3390/toxins8040122
Asai, M. et al. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem. Biophys. Res. Commun. 301, 231–235 (2003).
pubmed: 12535668
doi: 10.1016/S0006-291X(02)02999-6
Perampalam, P. et al. Disrupting the DREAM transcriptional repressor complex induces apolipoprotein overexpression and systemic amyloidosis in mice. J. Clin. Invest. 131, e140903 (2021).
pubmed: 33444292
pmcid: 7880409
doi: 10.1172/JCI140903
Yang, M. et al. Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure. Sci. Rep. 8, 5620 (2018).
pubmed: 29618729
pmcid: 5884826
doi: 10.1038/s41598-018-23755-y
Löffek, S., Schilling, O. & Franzke, C. W. Series “matrix metalloproteinases in lung health and disease”: biological role of matrix metalloproteinases: a critical balance. Eur. Respir. J. 38, 191–208 (2011).
pubmed: 21177845
doi: 10.1183/09031936.00146510
Nomden, M., Beljaars, L., Verkade, H. J., Hulscher, J. B. F. & Olinga, P. Current concepts of biliary atresia and matrix metalloproteinase-7: a review of literature. Front. Med. 7, 617261 (2020).
doi: 10.3389/fmed.2020.617261
Yang, L. et al. Diagnostic accuracy of serum matrix metalloproteinase-7 for biliary atresia. Hepatology 68, 2069–2077 (2018).
pubmed: 30153340
doi: 10.1002/hep.30234
Aldeiri, B. et al. Matrix metalloproteinase-7 and osteopontin serum levels as biomarkers for biliary atresia. J. Pediatr. Gastroenterol. Nutr. 77, 97–102 (2023).
pubmed: 37326848
doi: 10.1097/MPG.0000000000003792
Zhou, X. et al. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int. 24, 492–501 (2004).
pubmed: 15482348
doi: 10.1111/j.1478-3231.2004.0946.x
Otani, S. et al. Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells. Biochem. Biophys. Res. Commun. 469, 1062–1068 (2016).
pubmed: 26724533
doi: 10.1016/j.bbrc.2015.12.105
Jia, W., Rajani, C., Kaddurah-Daouk, R. & Li, H. Expert insights: the potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer’s disease and hepatic encephalopathy. Med. Res. Rev. 40, 1496–1507 (2020).
pubmed: 31808182
doi: 10.1002/med.21653
Asefa, N. G. et al. Bioinformatic prioritization and functional annotation of GWAS-based candidate genes for primary open-angle glaucoma. Genes 13, 1055 (2022).
pubmed: 35741817
pmcid: 9222386
doi: 10.3390/genes13061055
Coronel, R. et al. Amyloid precursor protein (APP) regulates gliogenesis and neurogenesis of human neural stem cells by several signaling pathways. Int. J. Mol. Sci. 24, 12964 (2023).
pubmed: 37629148
pmcid: 10455174
doi: 10.3390/ijms241612964
Tang, X. et al. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer’s disease. Sci. Rep. 13, 7816 (2023).
pubmed: 37188790
pmcid: 10185676
doi: 10.1038/s41598-023-34787-4